Guangdong, China

Dailong Fang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dailong Fang. Retrieved from https://idiyas.com/inventor/dailong-fang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dailong Fang: Innovator in Pharmaceutical Formulations

Introduction

Dailong Fang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on inclusion complexes.

Latest Patents

Dailong Fang holds a patent for "Vilazodone inclusion complexes, compositions and preparation thereof." This patent discloses inclusion complexes comprising vilazodone or a pharmaceutically acceptable salt thereof and an inclusion material. It also covers compositions and pharmaceutical formulations that include these inclusion complexes, along with methods for their preparation.

Career Highlights

Dailong Fang is associated with Sunshine Lake Pharma Co., Ltd., where he applies his expertise in pharmaceutical formulations. His work has been instrumental in advancing the development of new therapeutic options.

Collaborations

Dailong Fang collaborates with talented individuals such as Xiaomiao Qiu and Beiyang Yao, contributing to a dynamic research environment.

Conclusion

Dailong Fang's innovative work in the pharmaceutical industry, particularly with vilazodone inclusion complexes, showcases his commitment to advancing healthcare solutions. His contributions are paving the way for new therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…